Metformin-associated lactic acidosis

Journal of the American Board of Family Practice

Volumn 11, Issue 3, 1998, Pages 233-236

  Hulisz, Darrell T ^a,b,e   Bonfiglio, Mark F ^b,c   Murray, Richard D ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO NORTHERN UNIVERSITY   (United States)

^c AKRON GENERAL MEDICAL CENTER   (United States)

^d NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FUROSEMIDE; METFORMIN; PHENFORMIN;

ARTICLE; CLINICAL FEATURE; COMORBIDITY; DISEASE PREDISPOSITION; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; LACTIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SYMPTOMATOLOGY;

EID: 0032407419     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: 10.3122/15572625-11-3-233     Document Type: Article

References (16)

1. Lee AJ. Metformin in noninsulin-dependent diabetes mellitus. Pharmacotherapy 1996;16:327-51.
2. Schneider J, Erren T, Zofel P, Kaffarnik H. Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus. Atherosclerosis 1990;82:97-103.
3. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med 1992;152:2333-6.
4. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-9.
5. Gowardman JR. Fatal metformin induced lactic acidosis: case report. N Z Med J 1995;108:230-1.
6. McGuinness AIE, Talbert RL. Phenformin-induced lactic acidosis: a forgotten adverse drug reaction. Ann Pharmacother 1993;27:1183-7.
7. Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care 1990;13:696-704.
8. Oates NS, Shah RR, Idle JR, Smith RL. Influence of oxidation polymorphism on phenformin kinetics and dynamics. Clin Pharmacol Ther 1983;34:827-34.
9. Hutchison SM, Catterall JR. Metformin and lactic acidosis - a reminder. Br J Clin Pract 1987;41:673-4.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
11. D'Angio R, Platt DR, Gannon R. Creatinine clearance: corrected versus uncorrected. Drug Intell Clin Pharm 1988;22:32-3.
12. Somogyi A, Stockley C, Keal J, Rolan P, Bochner F. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 1987;23:545-51.
13. Lalau JD, Lacroix C, Compagnon P, de Cagny B, Rigaud JP, Bleichner G, et al. Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 1995;18:779-84.
14. Lalau JD, Lacroix C, De Cagny B, Fournier A. Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis. Nephrol Dial Transplant 1994;9(Suppl 4):126-9.
15. American Diabetes Association. Clinical practice recommendations - 1995. Diabetes Care 1995;18 (Suppl 1):1-96.
16. Kerr CP. Improving outcomes in diabetes: a review of the outpatient care of NIDDM patients. J Fam Pract 1995;40:63-75.